Free Morning Sentiment Digest: forex sentiment and new articles, in your inbox before the open. Free morning digest, every weekday.
SUBSCRIBE FREE

USD in focus as Fed holds rates steady; Lilly's retatrutide tops Ozempic

thestockmarketwatch.com Sentiment: Very Positive
The source reports no currency price move, pip figures or technical levels. The report, published October 28, 2026, pairs two headlines. First, the Federal Reserve held interest rates steady. The article excerpt gives no rate level, vote details or forward guidance. Second, Eli Lilly announced that its next-generation obesity treatment, retatrutide, significantly outperformed Novo Nordisk's Ozempic in what the source calls a landmark trial. The excerpt is cut off before the trial details. For forex traders, the Fed's decision to keep policy unchanged is the main item relevant to the US dollar. The Eli Lilly trial result is an equity- and sector-specific development with no stated currency impact. Because the source gives no market reaction, rate figures or Fed commentary, traders should look to the Fed's official statement and actual price action in USD pairs before drawing directional conclusions.

Related Symbols:

EURUSD

News data provided by Marketaux. ForexSentiment.live provides this summary as a convenience with proper attribution to the original source. The full article is available at the original publisher's website.

ChartJudge: an AI second opinion on your chart

Paste the chart you are looking at and get the trend, the key levels, bull and bear scenarios and a plan with entry, stop and two targets, or the setups worth waiting for. Behind every analysis on 29 markets is the Forex Sentiment engine: retail positioning, the five-factor signal, levels on real prices and the calendar. Free to try with a verified email, no card needed.

Analyze a chart free
ForexSentiment App
ForexSentiment Forex Sentiment & AI Signals
App Store Google Play